Innovation

3D visualization of the Westlake University super antibody neutralizing the SFTS virus.

Westlake University’s ‘Super Antibody’ ZS1C5 Targets Deadly SFTS Virus with 100% Survival in Animal Trials

Scientists at Westlake University have engineered a “super antibody” that achieved 100% survival in mice exposed to a deadly tick-borne virus. The therapy, called ZS1C5, slashed viral loads in monkeys by 90% in 24 hours, offering the first hope for a targeted treatment against SFTS—a disease with a 30% fatality rate and no current cure.

Read More...

Brigham and Women’s Hospital Enrolls First Patient in Groundbreaking Trial for Wandercraft’s Atalante X Exoskeleton

Researchers at Brigham and Women’s Hospital have enrolled the first patient in a unique trial for Wandercraft’s Atalante X robotic exoskeleton. The study will test if the hands-free, 12-joint device can safely mobilize fragile patients after thoracic surgery, aiming to improve recovery outcomes where traditional methods are challenging.

Read More...

China-Led Team Recreates Human Embryo “Invasion” of Womb

Scientists led by the Chinese Academy of Sciences have built the world’s first 3D “mini-womb on a chip” that fully mimics human embryo implantation. Reported in the journal Cell, the model could unlock personalized treatments for infertility, affecting one in six adults globally.

Read More...